Kidney research reveals a complex picture of life-saving treatments that show genuine promise but deliver frustratingly mixed ...

Similarly, since the late-1990s Toronto has been enjoying another boom, which has resulted in entirely new districts, such as ...

Rezolute, Inc. is downgraded to a Sell after its phase 3 sunRIZE trial for congenital hyperinsulinism failed. Learn more about RZLT stock here.

This important study reports three experiments examining how the subjective experience of task regularities influences perceptual decision-making. Although the evidence linking subjective ratings to ...

MicroPort NeuroTech Limited ($HK:2172) announced an update on their ongoing clinical study. Study Overview The clinical study “a Prospective, ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

Hopper Throttle MaxStax Soybean advanced planter box treatment copack on naked soybeans topped liquid seed treatment in the ...

For decades, osteoporosis has meant a slow, one way slide toward fragile bones and fracture risk, managed but rarely truly ...

An intervention to increase point-of-care ultrasound-guided regional anesthesia (POCUS-GRA) uptake by emergency physicians was safe, effective, and significantly reduced the odds of delirium. Evidence ...

Kallyope, a late-stage biotechnology company focused on developing innovative migraine and metabolic disease therapies for ...

The Company enters 2026 with Multiple Phase 2 Catalysts collectively representing ~$8 billion in potential market ...